K-V Pharmaceutical Co.’s lawsuit claiming U.S. regulators allowed “unlawful competition” to its Makena drug was revived as a federal appeals court ordered a lower-court judge to reconsider a ruling against the company.

Tagged with: FDA KV Pharmaceutical Co.

KV Pharmaceutical Co., a drugmaker whose shares have dropped 92 percent in the past year, said it settled a patent lawsuit with Purdue Pharma LP over the OxyContin painkiller. Under the agreement, KV acknowledges the validity and enforceability of Purdue’s ...

Tagged with: KV Pharmaceutical Co. OxyContin

KV Pharmaceutical Co., a St. Louis drugmaker, agreed to improve its manufacturing processes to resolve a U.S. Food and Drug Administration lawsuit filed in the wake of a shutdown of the company’s production. “We have been working diligently with the ...

Tagged with: Catherine Hanaway David Van Vliet drugmaker KV Pharmaceutical Co. U.S. Food and Drug Administration

KV Pharmaceutical Co., a St. Louis-based drug company, sued Citigroup Global Markets Inc., claiming the investment banking unit compelled it to buy $73.9 million worth of illiquid auction-rate securities. The Citigroup unit misled KV, telling it that the securities were ...

Tagged with: auction Citigroup Global Markets Inc. Citigroup UBS AG illiquid auction-rate securities KV Pharmaceutical Co. U.S. Securities and Exchange Commission